Individual patient data from registrational trials of silodosin in the treatment of non-neurogenic male lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH): subgroup analyses of efficacy and safety data.
about
α1-Blockers in Men with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Obstruction: Is Silodosin Different?Quality of life in patients with lower urinary tract symptoms associated with BPH: change over time in real-life practice according to treatment--the QUALIPROST study.Silodosin: a review of its use in the treatment of the signs and symptoms of benign prostatic hyperplasia.Effectiveness and safety of silodosin in the treatment of lower urinary tract symptoms in patients with benign prostatic hyperplasia: A European phase IV clinical study (SiRE study).Clinically Meaningful Improvements in LUTS/BPH Severity in Men Treated with Silodosin Plus Hexanic Extract of Serenoa Repens or Silodosin Alone.Silodosin for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.Prostate-selective α antagonists increase fracture risk in prostate cancer patients with and without a history of androgen deprivation therapy: a nationwide population-based study.
P2860
Q28070342-829345AE-D636-4EF4-BE2E-8A4521BE4435Q36820221-76FE7D93-7584-424C-906A-A2A60AE2BE60Q38313282-DC24FD66-FC1A-4AF6-BC7C-9DB4A3C40DBAQ39926524-7A1908BA-926B-40B3-8DF4-16717289645AQ45422268-91D0E912-81BA-4ACE-845D-2BE69265E5E1Q47434739-690928ED-007A-4AB9-A459-D489145920ACQ49538209-2E551EEA-C6E4-4FB1-8ACF-7FC58EC9B4A5
P2860
Individual patient data from registrational trials of silodosin in the treatment of non-neurogenic male lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH): subgroup analyses of efficacy and safety data.
description
2015 nî lūn-bûn
@nan
2015 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Individual patient data from r ...... s of efficacy and safety data.
@ast
Individual patient data from r ...... s of efficacy and safety data.
@en
type
label
Individual patient data from r ...... s of efficacy and safety data.
@ast
Individual patient data from r ...... s of efficacy and safety data.
@en
prefLabel
Individual patient data from r ...... s of efficacy and safety data.
@ast
Individual patient data from r ...... s of efficacy and safety data.
@en
P2860
P356
P1433
P1476
Individual patient data from r ...... s of efficacy and safety data.
@en
P2093
Christopher R Chapple
Giacomo Novara
P2860
P304
P356
10.1111/BJU.12906
P577
2015-05-01T00:00:00Z